Risk for coronary artery disease among individuals with normal low-density lipoprotein cholesterol (LDL-C) levels. [PDF]
Shi Z +13 more
europepmc +1 more source
Efficacy and Safety of Evolocumab in Improving Low-Density Lipoprotein Cholesterol (LDL-C) Levels in a Japanese Population - Systematic Review and Meta-Analysis. [PDF]
Sheng F +5 more
europepmc +1 more source
Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study. [PDF]
Li Z +14 more
europepmc +1 more source
Age-multiplied low density lipoprotein cholesterol (LDL-C) burden (AM-LDL) index stratifies bleeding and ischemic risk in acute coronary syndrome: implications for early therapeutic intensification. [PDF]
Yu Y, Wang Y, Tuo X, Li Z, Li D, Chen Y.
europepmc +1 more source
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
K. Ray +12 more
semanticscholar +1 more source
Assessment of Low-Density Lipoprotein Cholesterol (LDL-C) Target Attainment in High-Risk Patients Receiving Statin Plus Ezetimibe Therapy: A Retrospective Cross-Sectional Study. [PDF]
Umer Khatab Gillani SSUD +9 more
europepmc +1 more source
The clinical impact of estimating low-density lipoprotein cholesterol (LDL-C) using different equations in the general population. [PDF]
Lam R +13 more
europepmc +1 more source
A Comparative Analysis of Low-Density Lipoprotein Cholesterol (LDL-C)-Lowering Activities of Bempedoic Acid, Inclisiran, and PCSK9 Inhibitors: A Systematic Review. [PDF]
Rajendran Y +7 more
europepmc +1 more source

